FDA Investigator

Camilla S Smith

Latest inspection on record: Beaverton, United States, September 2025 · records back to 2016

Biologics

FDA inspection record · Last updated July 12, 2026

Overview

  • 31 inspections across 31 sites are on record.
  • 1 Form 483 observation is attributed to this investigator.
  • Most recent recorded activity is 2025-09-25.

At a glance

Inspections

31

Sites

31

Observations

1

Career since

May 2016

Recent inspections

Most recent inspections in the published record.

SiteDateCategoryForm 483
The American National Red Cross25 Sep 2025Biologics
The American National Red Cross18 Jul 2025Biologics
The American National Red Cross16 Jul 2025Biologics
Innovative Blood Resources, a Division of New York Blood Ceenter1 May 2025Biologics
Innovative Blood Resources, a Division of New York Blood Center29 Apr 2025Biologics

Sites inspected

The American National Red CrossBeaverton, United States1 insp.
The American National Red CrossEast Norriton, United States1 insp.
The American National Red CrossLanghorne, United States1 insp.
Innovative Blood Resources, a Division of New York Blood CeenterMaple Grove, United States1 insp.
Innovative Blood Resources, a Division of New York Blood CenterApple Valley, United States1 insp.

Co-investigators

Investigators who share inspections with this person.

Mona B Amin2 shared
Racquel N East2 shared
Jennifer L Custodio2 shared
Judy E Ciaraldi2 shared
Patricia E Weddington1 shared
Karen J Bak1 shared
Lisa L Caulder1 shared
William F Lagud1 shared

Full investigator report

Get the verbatim findings behind Camilla S Smith's 1 observation

Source 483 PDFs, verbatim observations, and how each site responded, so your team knows what they cite before they arrive.

  • New inspections and Form 483s, mapped to the CFR citation
  • Warning letter outcomes, and the citation patterns they repeat
  • Their co-investigators, so no surprises about who shows up on site

Related investigators